ClearPoint Neuro, Inc.
corporate_fare Company Profile
ClearPoint Neuro, Inc. (NASDAQ:CLPT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 18 items for CLPT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for CLPT spans 10-Q, 8-K, 144, DEF 14A.
Recent high-impact activity:
- ClearPoint Q3 Revenue Up 36% to $12.1M, But Net Loss Widens to $7.5M
- ClearPoint Neuro Q3 Revenue Jumps 36% to $12.1M; 2026 Guidance Set at $48-50M
- ClearPoint Neuro Q2 Loss Doubles as IRRAS Integration Costs Surge; Cash Burn Accelerates
- Officer Joseph Burnett Files Intent to Sell Additional $370K in Shares
- ClearPoint Neuro Officer Joseph Burnett Files Intent to Sell $800K in Shares
Financial Snapshot
Short Interest & Short Volume
6.56 days to coverFINRA reported short interest of 4,294,341 shares in CLPT as of the October 30, 2026 settlement, a 7.2% decrease from the prior period — about 6.6 days to cover at its recent average daily volume. On November 20, 2026, 51.1% of CLPT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for CLPT, detected from its recent SEC filings.
New $200M Shelf Registered · $100M ATM Program Established
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →